Science Explorer Interactive view Map
Company · San Diego · United States

Ligand Pharmaceuticals (United States)

In research, Ligand Pharmaceuticals (United States) stands highest in Life Sciences (#5,509 of 14,347 worldwide), Medicine (#12,396 of 17,978 worldwide) and Biochemistry, Genetics and Molecular Biology (#5,504 of 7,814 worldwide), over all time.

World rank, all time
#13,513
of 42,892
Rank in United States
#2,964
of 8,685
Research works
411
▲ 7% vs 2013–17
Citations
22k
53.5 per fractional work
Top-10% rate
13.0%
record average 16.5%
Open access
42%
world 28%

What is Ligand Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #5,509 of 14,347 24.3%229
MedicineField #12,396 of 17,978 27.3%139
Biochemistry, Genetics and Molecular BiologyField #5,504 of 7,814 24.3%181
Health SciencesDomain #15,547 of 20,462 27.2%141

Each strip is that field’s whole ranked pool, with the notch where Ligand Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.95× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 5.23× its world share, 0 worksImmunology and Micro…Neuroscience: 0.46× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.93× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.25× its world share, 0 worksChemistryComputer Science: 0.34× its world share, 0 worksComputer ScienceMaterials Science: 1.00× its world share, 0 worksMaterials ScienceMedicine: 2.37× its world share, 3 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.0×. Every wedge is a field page.

Who are the top researchers at Ligand Pharmaceuticals (United States)?

Ranked on the composite score, Todd K. Jones, Marcus F. Boehm and William W. Lamph lead among researchers whose main affiliation is Ligand Pharmaceuticals (United States).

  1. 1 Todd K. Jones United States · #474,459 worldwide 157 citations · 16 works
  2. 2 Marcus F. Boehm United States · #522,120 worldwide 83 citations · 19 works
  3. 3 William W. Lamph United States · #606,448 worldwide 121 citations · 16 works
  4. 4 Alex M. Nadzan United States · #788,294 worldwide 31 citations · 19 works
  5. 5 Richard A. Heyman United States · #932,911 worldwide 77 citations · 19 works
All ranked researchers at Ligand Pharmaceuticals (United States)

Which keywords describe research at Ligand Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Nuclear Receptors, Transcriptional Regulation, Breast Cancer, Signaling, Estrogen, Receptor, G Protein-Coupled Receptor and Glucocorticoids.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Nuclear Receptors115▲ 153×5 topics
  2. Transcriptional Regulation75▲ 73×6 topics
  3. Breast Cancer67▲ 58×7 topics
  4. Signaling65▲ 139×4 topics
  5. Estrogen64▲ 206×2 topics
  6. Receptor63▲ 213×2 topics
  7. G Protein-Coupled Receptor62▲ 229×2 topics
  8. Glucocorticoids62▲ 268×1 topic
  9. Tamoxifen62▲ 268×1 topic
  10. Inflammation56▲ 5.8×39 topics
  11. Gene Expression Regulation42▲ 89×2 topics
  12. Acute Promyelocytic Leukemia42▲ 342×1 topic
  13. Retinoic Acid42▲ 342×1 topic
  14. Cancer32▲ 5.6×23 topics
  15. Reactive Oxygen Species27▲ 13×10 topics
  16. Oxidative Stress25▲ 3.3×26 topics
  17. Anticancer Agents21▲ 20×6 topics
  18. Metabolic Syndrome20▲ 5.5×11 topics
  19. Cell Signaling18▲ 13×8 topics
  20. Pharmacology18▲ 14×7 topics
  21. Biomarkers17▲ 6.8×5 topics
  22. Diabetes17▲ 8.1×7 topics
  23. Apoptosis16▲ 9.7×8 topics
  24. Drug Discovery15▲ 9.4×8 topics
  25. Antimicrobial Activity15▲ 20×5 topics
  26. Hormone Therapy14▲ 33×3 topics
  27. Atherosclerosis14▲ 9.5×5 topics
  28. Antioxidants14▲ 8.1×4 topics
  29. Metabolism14▲ 5.1×12 topics
  30. Cardiovascular Risk14▲ 9.4×6 topics
  31. Medicinal Chemistry13▲ 8.2×7 topics
  32. Cancer Prevention12▲ 12×2 topics
  33. Carotenoids12▲ 75×1 topic
  34. Lipid Peroxidation12▲ 41×2 topics
  35. Vitamin E12▲ 75×1 topic
  36. Synthesis12▲ 5.0×14 topics
  37. Tumor Microenvironment12▲ 8.1×6 topics
  38. Heterocyclic Compounds11▲ 17×5 topics
  39. Toxicology10▲ 12×4 topics
  40. Cytotoxicity10▲ 18×5 topics

Which research topics does Ligand Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Ovarian cancer diagnosis and treatment, Testicular diseases and treatments and Estrogen and related hormone effects.

  1. 1 Acute Myeloid Leukemia Research Hematology 0 works
  2. 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
  3. 3 Testicular diseases and treatments Surgery 0 works
  4. 4 Estrogen and related hormone effects Genetics 0 works
  5. 5 Protein Degradation and Inhibitors Molecular Biology 0 works
  6. 6 Retinal Development and Disorders Molecular Biology 0 works
  7. 7 Hematopoietic Stem Cell Transplantation Hematology 0 works
  8. 8 Genetic Syndromes and Imprinting Genetics 0 works
  9. 9 Amino Acid Enzymes and Metabolism Biochemistry 0 works
  10. 10 Retinal Diseases and Treatments Ophthalmology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.8%not open58.2%

World: 28% of research is openly available.

with international co-authors10.2%domestic only89.8%

World: 19% is written across borders.

How has Ligand Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 7% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.